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CRE sites in vitro and in vivo. Mithramycin A, a 
competitive inhibitor of Spl binding to DNA, re- 
duced MIF promoter activity and mRNA levels in 
THP-1 ceils, whereas expression of Spl in Spl- 
deficient Sf9 insect ceils increased promoter activ- 
ity. Albeit located in a CpG island, MIF expression 
was not modulated by DNA methy[ation of its CpG 
sites. Steady state MIF mRNA levels correlated with 
mRNA haft-lives in HeLa, A549, HaCat and THP-1 
ceils suggesting that mRNA stability is a key deter- 
minant of ceil-specific post-transcriptional control 
of MIF expression. 
Conclusions: The present findings provide evidence 
imp[icating Spl and CREB and mRNA stabi[ity in 
transcriptional and post-transcriptional regulation 
of human MIF gene expression. The identification 
of the factors involved in the regulation of the 
constitutive MIF gene expression may provide im- 
portant insights into the molecular mechanisms 
leading to increased MIF expression in cancer and 
in inflammatory and auto-immune diseases. 
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Background: Histone deacety[ases (HDACs) are 
regulators of chromatin structure and gene expres- 
sion. Originally investigated as anticancer drugs, 
HDAC inhibitors (HDI) have emerged to be potent 
anti-inflammatory agents for auto-immune, allergic 
and inflammatory diseases. 
Objective: To investigate the effects of tri- 
chostatin A (TSA), a prototypica[ HDI, on pro- 
inflammatory cytokine expression by innate im- 
mune ceils exposed to microbial products. 
Methods: Mouse RAW 264.7, peritoneal and bone 
marrow-derived macrophages and dendritic ceils 
(DCs) and human whole blood were pre-incubated 
for 1 h with TSA (0-0.1 ~M) before stimulation with 
LPS, Pam3CSK4, peptidog[ycan, CpG DNA or heat- 
ki[[ed E. coli, S. aureus or C. albicans. Cytokine 
mRNA and protein expression were measured by 
Northern Noting and by ELISA. MHC II, CD40, CD80 
and CD86 expression by DCs was analyzed by flow 
cytometry. NF-kB activity was assessed by EMSA 
and transient transfection of RAW ceils with a kB- 
[uciferase reporter vector. Cytokine production was 
also measured 1 h after i.v. challenge with LPS 
(4~g/kg) and TSA (800~g/kg) in D-ga[actosamine- 
sensitized mice. 
Results: TSA was a potent inhibitor of TNF, IL-6 
and IL-12 production (up to 100% at 0.1 ~M TSA) 
by mouse macrophages, DCs and/or whole blood in 
response to a[[ microbial stimuli. TSA also strongly 
inhibited CD40 and CD86 up-regulation by DCs 
stimulated with LPS and Pam3CSK4. Inhibition of 
LPS and Pam3CSK4 induced TNF release by TSA- 
treated RAW 264.7 macrophages was associated 
with: (1) >75% inhibition of TNF mRNA levels, 
(2) reduced nuclear trans[ocation of NF-kB, and 
(3) marked inhibition (10-fold) of NF-kB-mediated 
transcriptional activity. In vivo, administration of 
TSA resulted in a striking inhibition (>90%, P =0.02) 
of LPS-induced IL-6 release. 
Conclusions: HDAC inhibitors exhibit profound in- 
hibitory effects on innate immune gene expres- 
sion by macrophages and dendritic ceils exposed 
to microbial products. These results suggest that 
HDI might be a new class of immunomodu[ators 
that deserve further investigation as anti-sepsis 
agents. Yet, these observations also suggest that 
HDI might impair innate immune defenses and thus 
predispose cancer patients who are treated with 
these agents to severe infections. 
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Background: Increased expression or activity of 
histone deacety[ases (HDACs) have been detected 
in cancer ceils, which strengthened development 
of pharmacological inhibitors of HDACs (HDIs). HDIs 
were observed to induce the differentiation and 
the apoptosis of tumor ceils in vitro, so that several 
of these drugs are currently being tested as anti- 
cancer agents in clinical trials. Yet, the molecular 
basis of the anti-tumoral effects of HDIs is not 
fully understood. Macrophage migration inhibitory 
factor (MIF), a pro-inflammatory cytokine, has re- 
cently been implicated in ceil proliferation, angio- 
genesis and oncogenesis and may therefore repre- 
sent a novel target of HDI action. 
Objective: To study whether HDIs modify the ex- 
pression of MIF in human ceils. 
Methods: Human whole blood, HeLa cervix epithe- 
lial ceils, HaCat keratinocytes and U-937, KGla and 
HL-60 leukemic ceil lines were exposed to tricho- 
statin A (TSA), a prototypica[ HDI. MIF gene tran- 
scription, mRNA, protein and fuji-length, truncated 
or mutated promoter activities were assessed by 
